Medeon Biodesign, Inc. (TPEX:6499)

Medeon Biodesign Revenue

Medeon Biodesign had revenue of 92.30M TWD in the quarter ending September 30, 2025, a decrease of -11.93%. This brings the company's revenue in the last twelve months to 381.90M, up 40.96% year-over-year. In the year 2024, Medeon Biodesign had annual revenue of 292.81M with 49.19% growth.

• Revenue (ttm): 381.90M
• Revenue Growth: +40.96%
• P/S Ratio: 22.85
• Revenue / Employee: 9.79M
• Employees: 39
• Market Cap: 8.73B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	292.81M	96.55M	49.19%
Dec 31, 2023	196.26M	-102.05M	-34.21%
Dec 31, 2022	298.32M	229.36M	332.61%
Dec 31, 2021	68.96M	-54.10M	-43.96%
Dec 31, 2020	123.06M	-330.71M	-72.88%